SkinBioTherapeutics Plc

Status: Publicly traded

Direct answer

SkinBioTherapeutics Plc is publicly traded on LSE under the ticker SBTX.L.

SkinBioTherapeutics Plc is a life sciences enterprise dedicated to enhancing human health through the exploration and development of technologies that harness the power of the human microbiome. The company has developed two primary technological platforms: SkinBiotix: This innovative solution is designed to strengthen the skin's natural barrier, offer protection against infections, and promote the repair of damaged...

Can you invest in SkinBioTherapeutics Plc?

Yes. SkinBioTherapeutics Plc is publicly traded on LSE under the ticker SBTX.L.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for SkinBioTherapeutics Plc

Detailed equity research is provided by MarketSnap.